Furthermore, flow cytometric analysis of tumor-infiltrating CD45+ immune cells in samples from individuals with PDAC and in both KPC FC1245 and Panc02 tumors displayed P2Y6 expression in TAMs (mostly in the CD206+ subset) and tumor-infiltrating neutrophils (TANs; Fig. 6c–e). This evidence concerns the gene MRC1 and neoplasm.